Overview

Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Administration of a single 50 mg or 200 mg dose of tigecycline will not cause a change in QT/QTc intervals.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Minocycline
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Tigecycline